Rare lephants
Screener

SELLAS Life Sciences Group, Inc.

SLS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
DEFA14A Apr 28, 2023 DEFA14A
DEF 14A Apr 28, 2023 DEF 14A
PRE 14A Apr 17, 2023 PRE 14A
S-8 Mar 16, 2023 FORM S-8
8-K Mar 16, 2023 8-K
10-K Mar 16, 2023 10-K
8-K Mar 10, 2023 FORM 8-K
8-K Mar 1, 2023 FORM 8-K
424B5 Feb 24, 2023 424B5
8-K Feb 24, 2023 FORM 8-K
424B5 Feb 23, 2023 424B5
8-K Feb 23, 2023 FORM 8-K
8-K Feb 6, 2023 FORM 8-K
4 Feb 3, 2023 OWNERSHIP DOCUMENT
4 Feb 3, 2023 OWNERSHIP DOCUMENT
4 Feb 3, 2023 OWNERSHIP DOCUMENT
4 Feb 3, 2023 OWNERSHIP DOCUMENT
4 Feb 3, 2023 OWNERSHIP DOCUMENT
4 Feb 3, 2023 OWNERSHIP DOCUMENT
4 Feb 3, 2023 OWNERSHIP DOCUMENT
4 Feb 3, 2023 OWNERSHIP DOCUMENT
4 Feb 3, 2023 OWNERSHIP DOCUMENT
8-K Dec 13, 2022 FORM 8-K
4 Dec 5, 2022 OWNERSHIP DOCUMENT
4 Dec 5, 2022 OWNERSHIP DOCUMENT
← Newer Page 7 of 51 · 1272 filings Older →